Is Carotid Intima-Media Thickness Useful in Predicting Renal Insufficiency in Asymptomatic Hypertensive Patients Attending a Tertiary Hospital in Nigeria?
DOI:
https://doi.org/10.60787/tnhj.v19i3.446Keywords:
Carotid Intima-Media Thickness, Hypertensive, Renal Insufficiency, AsymptomaticAbstract
Background: Intima-media thickness of the carotid artery wall (CIMT) is a strong predictor of cardiovascular disease (CVD). The aim of this study was to investigate the association between CIMT and renal insufficiency as determined by the estimated glomerular filtration rate (eGFR), as well as determine the ability of CIMT to predict the presence of covert renal insufficiency in hypertensive Nigerian adults.
Method: Two hundred and sixteen participants took part in the study, comprising of 72 hypertensive patients on antihypertensive medication (treated), 72 newly-diagnosed patients, and 72 apparently healthy, normotensive subjects. The eGFR was determined from serum creatinine using the Cockroft-Gault formula, while the CIMT was determined by carotid ultrasonography.
Result: There was no significant difference in the mean age of the study population (p=0.073). CKD was found more in patients with increased CIMT (33.5%), than in those with normal CIMT (6.5%) (x2=12.170, p<0.0001). CKD was also most prevalent in the untreated hypertensive patients than in any of the other groups (x2=15.022, p=0.011).
Patients with increased CIMT suffered from a lower glomerular filtration rate (p<0.0001). The decline in eGFR with increasing CIMT had a significant inverse correlation in the untreated group (r=-0.391, p=0.013). The predictability of renal insufficiency by CIMT determined using the Receiver Operating Characteristics (ROC) curve, showed an area under the curve (AUC) of 0.807 (95% CI: 0.708-0.907) (p<0.0001).
Conclusion: CIMT is a strong and independent predictor of renal insufficiency in the untreated hypertensive adult Nigerian patients and should be considered a valuable tool for cardiovascular risk stratification in this population group.
Downloads
References
Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
Halle MP, Ashuntantang G, Kaze FF, et al. Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala General Hospital in Cameroon. BMC Nephrology 2016; 17:165 DOI 10.1186/s12882-016-0377-5
De LeeuwPW, Thijs L, Birkenhäger WH, et al. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J Am SocNephrol 2002; 13: 2213-2222.
Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590.
Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J RespirCrit Care Med 2007; 176: 532–555.
Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514–1519.
Engstrom G, Lind P, Hedblad B et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555–2560.
Jousilahti P, Vartiainen E, Tuomilehto J et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567– 572.
Geper AD, Keevil JG, Wyman RA, et al. Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction. J Am SocEchocardiogr 2006; 19: 1170-1174.
Lakka TA, Salonen R, Kaplan GA, et al. Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension 1999; 34: 51-56.
Dharmashankar k, Widlansky ME. VascularEendothelialfunction and hypertension: Insights and Directions. CurrHypertens Rep. 2010; 12(6): 448–455. doi:10.1007/s11906-010-0150-2.
Hong MY. Atherosclerotic vascular disease beginning in childhood. Korean Circ J 2010; 40: 11-9
Oren A,Lydia EV, CunoSPM, et al.Cardiovascular risk factors and increased carotid intima media thickness in healthy young adults: The Atherosclerosis Risks in Young Adults (ARYA) study. Arch Intern Med 2003; 163: 1787-1792.
Olecnowicz-Tietz S, Gluba A, Paradowska A, et al. The risk of atherosclerosis in patients with chronic kidney disease. IntUroNephrol2013; 45:1605-1612.
Skora B, Gluba A,Banach M, et al. Acute coronary syndrome in patients with chronic kidney disease. Currently VascPharmacol2013; 11(5): 758-767.
Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardiol Clin. 2010 Nov; 28(4): 571–586.doi: 10.1016/j.ccl.2010.07.006
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–34.
van Deventer HE, George JA, Paiker JE. Estimating Glomerular Filtration Rate in Black South Africans by Use of the Modification of Diet in Renal Disease and Cockcroft-Gault Equations. Clinical Chemistry 2008; 54 (7): 1197–1202.
Salonen JT, Salonen R. ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: 1245-1249.
Okeahialam BN, Alonge BA, Puepet FH, et al. Carotid intima-media thickness as a measure of cardiovascular disease burden in Nigerian Africans with hypertension and diabetes mellitus. International Journal of Vascular Medicine Volume 2011, Article ID 327171, 4 pages doi:10.1155/2011/327171.
US Renal Data System: USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
Excerpts from the United States Renal Data System’s 2000 Annual Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2000; 36[Suppl 2]: S1–S137.
Kawamoto R, Ohtsuka N, Kusunoki T, et al. An association between the estimated glomerular filtration rate and carotid atherosclerosis. Inter Med 2008; 47: 391-398.
Beddhu S, Allen-Brady K, Cheung AK, et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 2002; 62: 1776 –1783.
Zhang L, Zhao F, Yang Y et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis 2007; 49: 856-862.
Lawal OM, Balogun MO, Akintomide AO, et al. Carotid intima-media thickness: A surrogate marker for cardiovascular disease in chronic kidney disease patients. Clinical Medicine Insights: Cardiology 2019; 13: 1-9.
Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events- the PREVENT investigators. Circulation 2001; 103: 919-925.
Kuswardhani RAT, Wiradharma KG, KadaraniY, et al. Factors associated with carotid intima-media thickness in patients on maintenance hemodialysis. International Journal of General Medicine 2019:12 1–6
Helal I, Smaoui W, Hamida FB, et al. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients. Saudi J Kidney Dis Transpl. 2010; 21(1):59–62.
deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353–359.
Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005; 16: 1141–1148.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
